The cystine/glutamate antiporter: When too much of a good thing goes bad

Journal of Clinical Investigation

Volumn 124, Issue 8, 2014, Pages 3279-3281

  Reissner, Kathryn J ^a  

^a The University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CYSTINE GLUTAMATE ANTIPORTER; GLUCOSE; GLUTAMATE RECEPTOR; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; GLUTATHIONE; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; OXYGEN; UNCLASSIFIED DRUG; AMINO ACID TRANSPORTER; SLC7A11 PROTEIN, MOUSE;

BRAIN INJURY; BRAIN ISCHEMIA; EXCITATORY POSTSYNAPTIC POTENTIAL; EXCITOTOXICITY; HOMEOSTASIS; HUMAN; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL MEMBRANE STEADY POTENTIAL; NONHUMAN; OXIDATION REDUCTION STATE; POSTSYNAPTIC MEMBRANE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; REVIEW; UPREGULATION; ANIMAL; PHYSIOLOGY; SECRETION (PROCESS);

AMINO ACID TRANSPORT SYSTEM Y+; ANIMALS; BRAIN ISCHEMIA; GLUTAMIC ACID;

EID: 84905453339     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI76627     Document Type: Review

References (17)

1. Hertz L. Bioenergetics of cerebral ischemia: a cellular perspective. Neuropharmacology. 2008;55(3):289-309.
2. Hamann M, Rossi DJ, Mohr C, Andrade AL, Attwell D. The electrical response of cerebellar Purkinje neurons to simulated ischaemia. Brain. 2005;128(pt 10):2408-2420.
3. Weilinger NL, Tang PL, Thompson RJ. Anoxia-induced NMDA receptor activation opens pannexin channels via Src family kinases. J Neurosci. 2012;32(36):12579-12588.
4. Soria FN, et al. Extrasynaptic glutamate release through cystine/glutamate antiporter contributes to ischemic damage. J Clin Invest. 2014;124(8):3645-3655.
5. Grewer C, Gameiro A, Zhang Z, Tao Z, Braams S, Rauen T. Glutamate forward and reverse transport: from molecular mechanism to transportermediated release after ischemia. IUBMB Life. 2008;60(9):609-619.
6. Camacho A, Massieu L. Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death. Arch Med Res. 2006;37(1):11-18.
7. Baker DA, Xi ZX, Shen H, Swanson CJ, Kalivas PW. The origin and neuronal function of in vivo nonsynaptic glutamate. J Neurosci. 2002;22(20):9134-9141.
8. Shih AY, Erb H, Sun X, Toda S, Kalivas PW, Murphy TH. Cystine/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation. J Neurosci. 2006;26(41):10514-10523.
9. Bridges R, Lutgen V, Lobner D, Baker DA. Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling. Pharmacol Rev. 2012;64(3):780-802.
10. Lewerenz J, et al. The cystine/glutamate antiporter system x (c) (-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal. 2013;18(5):522-555.
11. Moran MM, McFarland K, Melendez RI, Kalivas PW, Seamans JK. Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking. J Neurosci. 2005;25(27):6389-6393.
12. Parsons MP, Raymond LA. Extrasynaptic NMDA receptor involvement in central nervous system disorders. Neuron. 2014;82(2):279-293.
13. Hardingham GE, Bading H. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci. 2010;11(10):682-696.
14. Conrad M, Sato H. The oxidative stress-inducible cystine/glutamate antiporter, system x (c) (-): cystine supplier and beyond. Amino Acids. 2012;42(1):231-246.
15. Knuckey NW, Palm D, Primiano M, Epstein MH, Johanson CE. N-acetylcysteine enhances hippocampal neuronal survival after transient forebrain ischemia in rats. Stroke. 1995;26(2):305-310.
16. Cuzzocrea S, et al. Beneficial effects of n-acetylcysteine on ischaemic brain injury. Br J Pharmacol. 2000;130(6):1219-1226.
17. Bavarsad Shahripour R, Harrigan MR, Alexandrov AV. N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities. Brain Behav. 2014;4(2):108-122.